Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation

Carcinogenesis

Volumn 29, Issue 6, 2008, Pages 1148-1156

  Seaton, Angela ^a   Scullin, Paula ^a   Maxwell, Pamela J ^a   Wilson, Catherine ^a   Pettigrew, Johanna ^a   Gallagher, Rebecca ^a   O'Sullivan, Joe M ^a   Johnston, Patrick G ^a   Waugh, David J J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALPHA CHEMOKINE; ANDROGEN; ANDROGEN RECEPTOR; AZ 10397767; BICALUTAMIDE; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CXCR2; CYCLIN DEPENDENT KINASE 2; INTERLEUKIN 8; LUCIFERASE; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT INTERLEUKIN 8;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN LNCAP; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; PHASE TRANSITION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANDROGEN ANTAGONISTS; ANILIDES; ANTINEOPLASTIC AGENTS, HORMONAL; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-8; MALE; NITRILES; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECEPTORS, INTERLEUKIN-8B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOSYL COMPOUNDS; TRANSFECTION;

EID: 46949098184     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn109     Document Type: Article

References (44)

1. Debes,J.D. et al. (2004) Mechanisms of androgen refractory prostate cancer. N. Engl. J. Med., 351, 1488-1490.
2. Pienta,K.J. et al. (2006) Mechanisms underlying the development of androgen-independent prostate cancer. Clin. Cancer Res., 12, 1665-1671.
3. Culig,Z. et al. (1998) Expression, structure and function of androgen receptor in advanced prostatic carcinoma. Prostate, 35 63-70.
4. Cronauer,M.V. et al. (2003) The androgen receptor in hormone-refractory prostate cancer: Relevance of different mechanisms of androgen receptor signalling. Int. J. Oncol., 23, 1095-1102.
5. Taplin,M.E. et al. (2004) Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence. J. Cell. Biochem., 91, 483-490.
6. Chen,C.D. et al. (2004) Molecular determinants of resistance to anti-androgen therapy. Nat. Med., 10, 33-39.
7. Jia,L. et al. (2006) Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Mol. Cell. Biol., 26, 7331-7341.
8. Scher,H.I. et al. (2004) Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer. Endocr. Relat. Cancer, 11, 459-476.
9. Culig,Z. et al. (1994) Androgen receptor activation in prostatic tumour cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor. Cancer Res., 54, 5474-5478.
10. Lee,L.F. et al. (2001) Neuropeptide-induced androgen independence in prostate cancer cells: Roles of non-receptor tyrosine kinases Etk/ Bmx, Src and focal adhesion kinase. Mol. Cell. Biol., 21, 8385-8397.
11. Hobisch,A. et al. (1998) Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res., 58, 4640-4645.
12. Inoue,K. et al. (2000) Interleukin-8 expression regulates tumourigenicity and metastases in androgen-independent prostate cancer. Clin. Cancer Res., 6, 2104-2119.
13. Kim,S.J. et al. (2001) Expression of interleukin-8 correlates with angiogenesis, tumourigenicity and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia, 3, 33-42.
14. Veltri,R.W. et al. (1999) Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. Cancer, 91, 2322-2328.
15. McCarron,S.L. et al. (2002) Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res., 62, 3369-3372.
16. Murphy,C. et al. (2005) Non-apical and cytoplasmic expression of interleukin-8, CXCR1 and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer. Clin. Cancer Res., 11 4117-4127.
17. Uehara,H. et al. (2005) Expression of interleukin-8 gene in radical prostatectomy specimens is associated with advanced pathologic stage. Prostate, 64, 40-49.
18. Lee,L.F. et al. (2004) Interleukin-8 confers androgen-independent growth and migration of LNCaP: Differential effects of tyrosine kinases Src and FAK. Oncogene, 23, 2197-2205.
19. Lee,S.O. et al. (2003) Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway. Oncogene, 22, 7981-7988.
20. McDonald,S. et al. (2000) Ligand responsiveness in human prostate cancer: Structural analysis of mutant androgen receptors from LNCaP and CWR22 tumours. Cancer Res., 60, 2317-2322.
21. Sramkoski,R.M. et al. (1999) A new human prostate carcinoma cell line, 22RV1. In Vitro Cell. Dev. Biol. Anim., 35, 403-409.
22. Stamey,T.A. et al. (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med., 317, 909-916.
23. Lu,J. et al. (1997) Regulation of androgen-dependent prostatic cancer cell growth: Androgen regulation of CDK2, CDK4 and CKI p16 genes. Cancer Res., 57, 4511-4516.
24. Gregory,C.W. et al. (2001) Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function I the CWR22 human prostate cancer xenograft. J. Androl., 22, 537-548.
25. Hobisch,A. et al. (1995) Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res., 55 3068-3072.
26. van der Kwast,T.H. et al. (1991) Androgen receptors in endocrine-therapy-resistant human prostate cancer. Int. J. Cancer, 48, 189-193.
27. Agoulnik,I.U. et al. (2006) Androgen receptor action in hormone-dependent and recurrent prostate cancer. J. Cell. Biochem. 99, 362-372.
28. Araki,S. et al. (2007) Interleukin-8 is a molecular determinant of androgen-independence and progression in prostate cancer. Cancer Res. 67, 6854-6862.
29. Zhang,L. et al. (2004) Nuclear factor-κB activates transcription of the androgen receptor gene in sertoli cells isolated from testes of adult rats. Endocrinology, 145, 781-789.
30. Lee,S.O. et al. (2005) Requirement of NF-κB in interleukin-4-induced androgen receptor activation in prostate cancer cells. Prostate, 64, 160-167.
31. Bubulya,A. et al. (1996) c-Jun can mediate androgen receptor-induced transactivation. J. Biol. Chem., 271, 24583-24589.
32. Chen,S.Y. et al. (2006) c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation. Oncogene, 25, 7212-7223.
33. MacManus,C.F. et al. (2007) Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells. Mol. Cancer Res., 5, 737-748.
34. Fang,Y. et al. (1996) Hsp90 regulates androgen receptor hormone binding affinity in vivo. J. Biol. Chem., 271, 28697-28702.
35. Georget,V. et al. (2002) Mechanism of anti-androgen action: Key role of hsp90 in conformational change and transcriptional activity of the androgen receptor. Biochemistry, 41, 11824-11831.
36. Gioeli,D. et al. (2002) Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J. Biol. Chem., 277, 29304-29314.
37. Gioeli,D. (2005) Signal transduction in prostate cancer progression. Clin. Sci., 108, 293-308.
38. Weber,M.J. et al. (2004) Ras signalling in prostate cancer progression. J. Cell. Biochem., 91, 13-25.
39. Bakin,R.E. et al. (2003) Constitutive activation of the Ras/ mitogen-activated protein kinase signalling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells. Cancer Res., 63, 1981-1989.
40. Lu,S. et al. (2006) PI3K-Akt signalling is involved in the regulation of p21WAF/CIP expression and androgen-independent growth in prostate cancer cells. Int. J. Oncol., 28, 245-251.
41. Ueda,T. et al. (2002) Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells. J. Biol. Chem., 277, 38087-38094.
42. Gregory,C.W. et al. (2004) Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer. Cancer Res., 61, 2892-2898.
43. Burger,M. et al. (2005) KSHV-GPCR and CXCR2-transforming capacity and angiogenic responses are mediated through a JAK2-STAT3 dependent pathway. Oncogene, 24, 2067-2075.
44. Maxwell,P.J. et al. (2007) HIF-1 and NK-κB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells. Oncogene, 26, 7333-7345.